Sarolaner, Moxidectin And Pyrantel

16 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

620.0%

Death Rate

Active Ingredients

Sarolaner, Moxidectin And Pyrantel

Administration Routes

OralUnknown

Species Affected

Dog 16

Most Affected Breeds

Shepherd Dog - German 2

Dog (other) 2

Retriever - Labrador 1

Beagle 1

Dog (unknown) 1

Terrier - Silky 1

Terrier - Jack Russell 1

Terrier - West Highland White 1

Siberian Husky 1

Pointing Dog - German Short-haired 1

Most Reported Reactions

Lack of efficacy (endoparasite) - heartworm 2

Vomiting 2

Emesis (multiple) 2

Elevated serum alkaline phosphatase (SAP) 2

Blood in vomit 2

Bloody diarrhoea 2

Lack of efficacy - NOS 2

Decreased body temperature 2

Diarrhoea 2

Lethargy (see also Central nervous system depression in Neurological) 2

Overdose 1

Elevated aspartate aminotransferase (AST) 1

Outcome Breakdown

Outcome Unknown

8 (50.0%)

Recovered/Normal

4 (25.0%)

Ongoing

3 (18.8%)

Died

1 (6.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.